The absence of BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers is another potential mechanism of primary resistance [42], even if the topic is debated and evidences on breast cancer are still lacking. This evidence concerns the gene BRCA1 and breast carcinoma.